Hybrid neurofibroma/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients

American Journal of Surgical Pathology

Volumn 36, Issue 5, 2012, Pages 702-709

  Harder, Anja ^a   Wesemann, Martin ^a   Hagel, Christian ^c   Schittenhelm, Jens ^e   Fischer, Susan ^a   Tatagiba, Marcos ^f   Nagel, Christoph ^f   Jeibmann, Astrid ^a   Bohring, Axel ^b   Mautner, Victor Felix ^d   Paulus, Werner ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c Institute of Neuropathology   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e Institute of Pathology and Neuropathology   (Germany)

^f UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

hybrid neurofibroma schwannoma; hybrid tumor; nerve sheath tumor; neurofibromatosis; NF1; NF2; schwannomatosis; SMARCB1

Indexed keywords

TUMOR MARKER;

ADULT; ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; NEURILEMOMA; NEUROFIBROMA; NEUROFIBROMATOSIS; PATHOLOGY; RETROSPECTIVE STUDY; SKIN TUMOR;

ADULT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEURILEMMOMA; NEUROFIBROMA; NEUROFIBROMATOSES; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84859915136     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31824d3155     Document Type: Article

References (35)

1. Antinheimo J, Sankila R, Carpen O, et al. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology. 2000;54:71-76. (Pubitemid 30038740)
2. Bacci C, Sestini R, Provenzano A, et al. Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation. Neurogenetics. 2010;11:73-80.
3. Baser ME, Friedman JM, Evans DG. Increasing the specificity of diagnostic criteria for schwannomatosis. Neurology. 2006;66:730-732. (Pubitemid 43739830)
4. Boyd C, Smith MJ, Kluwe L, et al. Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet. 2008;74:358-366.
5. Carroll SL. Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms. Acta Neuropathol. 2012;123:321-348.
6. Chaubal A, Paetau A, Zoltick P, et al. CD34 immunoreactivity in nervous system tumors. Acta Neuropathol. 1994;88:454-458.
7. Christiaans I, Kenter SB, Brink HC, et al. Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas.J Med Genet. 2011;48:93-97.
8. Dubuisson A, Fissette J, Vivario M, et al. A benign tumor of the sciatic nerve: case report and review of the literature. Acta Neurol Belg. 1991;91:5-11.
9. Eaton KW, Tooke LS, Wainwright LM, et al. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer. 2011;56:7-15.
10. Feany MB, Anthony DC, Fletcher CD. Nerve sheath tumours with hybrid features of neurofibroma and schwannoma: a conceptual challenge. Histopathology. 1998;32:405-410. (Pubitemid 28231372)
11. Gonzalvo A, Fowler A, Cook RJ, et al. Schwannomatosis, sporadic schwannomatosis, and familial schwannomatosis: a surgical series withlong-term follow-up. Clinical article. J Neurosurg. 2011;114:756-762.
12. Hadfield KD, Newman WG, Bowers NL, et al. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. J Med Genet. 2008;45:332-339. (Pubitemid 351839473)
13. Hadfield KD, Smith MJ, Urquhart JE, et al. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. Oncogene. 2010;29:6216-6221.
14. Halliday AL, Sobel RA, Martuza RL. Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2. J Neurosurg. 1991;74:248-253.
15. Harkin J, Reed R. Tumors of the peripheral nervous system. Ser 2, Fasc 3, Washington, DC: Armed Forces Institue of Pathology; 1969:29-59.
16. Hulsebos TJ, Plomp AS, Wolterman RA, et al. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet. 2007;80:805-810. (Pubitemid 46564417)
17. Kayem MJ, Dufour JJ, Robert F. Development of a schwannoma within a facial nerve neurofibroma: a case report and literature review. Otolaryngol Head Neck Surg. 1995;112:483-487.
18. MacCollin M, Chiocca EA, Evans DG, et al. Diagnostic criteria for schwannomatosis. Neurology. 2005;64:1838-1845. (Pubitemid 40800695)
19. MacCollin M, Willett C, Heinrich B, et al. Familial schwannomatosis: exclusion of the NF2 locus as the germline event. Neurology. 2003;60:1968-1974. (Pubitemid 36736014)
20. MacCollin M, Woodfin W, Kronn D, et al. Schwannomatosis: a clinical and pathologic study. Neurology. 1996;46:1072-1079. (Pubitemid 26134655)
21. Masson C. Tumeurs humaines. Paris: Libraire Maloine; 1968:921-971.
22. McClatchey AI. Neurofibromatosis. Annu Rev Pathol. 2007;2:191-216. (Pubitemid 46448064)
23. Murarescu ED, Ivan L, Mihailovici MS. Neurofibroma, schwannoma or a hybrid tumor of the peripheral nerve sheath? Rom J Morphol Embryol. 2005;46:113-116.
24. Naber U, Friedrich RE, Glatzel M, et al. Podoplanin and CD34 in peripheral nerve sheath tumours: focus on neurofibromatosis 1-associated atypical neurofibroma. J Neurooncol. 2011;103:239-245.
25. Nielsen AB, Jensen HE, Leifsson PS. Immunohistochemistry for 20,30-cyclic nucleotide-30-phosphohydrolase in 63 bovine peripheral nerve sheath tumors. Vet Pathol. 2011;48:796-802.
26. Rodriguez FJ, Scheithauer BW, George D, et al. Superficial neurofibromas in the setting of schwannomatosis: nosologic implications. Acta Neuropathol. 2011;121:663-668.
27. Rousseau G, Noguchi T, Bourdon V, et al. SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis. BMC Neurol. 2011;11:9.
28. Scheithauer BW, Woodruff JM, Erlandson RA. Tumours of the peripheral nervous system.Washington, DC: Armed Forces Institute of Pathology; 1999.
29. Sestini R, Bacci C, Provenzano A, et al. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosisassociatedschwannomas. Hum Mutat. 2008;29:227-231. (Pubitemid 351240594)
30. Sintzoff SA Jr, Bank WO, Gevenois PA, et al. Simultaneous neurofibroma and schwannoma of the sciatic nerve. Am J Neuroradiol. 1992;13:1249-1252.
31. Spinner RJ, Scheithauer BW, Perry A, et al. Colocalized cellular schwannoma and plexiform neurofibroma in the absence of neurofibromatosis. Case report. J Neurosurg. 2007;107:435-439. (Pubitemid 47219392)
32. Swensen JJ, Keyser J, Coffin CM, et al. Familial occurrence of schwannomas and malignant rhabdoid tumour associated witha duplication in SMARCB1. J Med Genet. 2009;46:68-72.
33. Weiss SW, Nickoloff BJ. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol. 1993;17:1039-1045. (Pubitemid 23289346)
34. Yamamoto O, Suenaga Y, Imayama S, et al. Formation of nerve twig-like nests and schwannoma in an unusual case of neurofibroma.Acta Pathol Jpn. 1990;40:775-779.
35. Youens KE, Woodward J, Wallace D, et al. Hybrid neurofibromaschwannoma of the orbit. Orbit. 2008;27:223-225.